• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上消化道疾病50年进展概述

Overview of 50 years' progress in upper gastrointestinal diseases.

作者信息

Yeomans Neville D

机构信息

School of Medicine, University of Western Sydney, Penrith South DC, New South Wales, Australia.

出版信息

J Gastroenterol Hepatol. 2009 Oct;24 Suppl 3:S2-4. doi: 10.1111/j.1440-1746.2009.06064.x.

DOI:10.1111/j.1440-1746.2009.06064.x
PMID:19799693
Abstract

There have been numerous and dramatic advances in our understanding of the mechanisms, causes and treatments of upper gastrointestinal diseases in the past 50 years. This review focuses on a few, not dealt with elsewhere in this special issue of the Journal. The early history of the recognition that nonsteroidal anti-inflammatory drugs are a major cause of peptic ulcer is described, with particular attention to the work of the pioneering Australian investigators. The story of the development of the histamine H(2)-receptor antagonists and the proton pump inhibitors is also outlined.

摘要

在过去50年里,我们对上消化道疾病的机制、病因及治疗的理解取得了众多重大进展。本综述聚焦于其中一些内容,本刊这一特刊的其他地方未作讨论。文中描述了非甾体抗炎药是消化性溃疡主要病因这一认识的早期历史,特别关注了澳大利亚先驱研究者的工作。还概述了组胺H2受体拮抗剂和质子泵抑制剂的研发历程。

相似文献

1
Overview of 50 years' progress in upper gastrointestinal diseases.上消化道疾病50年进展概述
J Gastroenterol Hepatol. 2009 Oct;24 Suppl 3:S2-4. doi: 10.1111/j.1440-1746.2009.06064.x.
2
Experimental production of peptic ulcer, gastric damage and cancer models and their use in pathophysiological studies and pharmacological treatment--Polish achievements.消化性溃疡、胃损伤及癌症模型的实验性构建及其在病理生理学研究和药物治疗中的应用——波兰的研究成果
J Physiol Pharmacol. 2003 Dec;54 Suppl 3:99-126.
3
Landmarks in the understanding and treatment of reflux disease.
J Gastroenterol Hepatol. 2009 Oct;24 Suppl 3:S5-S14. doi: 10.1111/j.1440-1746.2009.06065.x.
4
New pharmacologic therapies in gastrointestinal disease.胃肠道疾病的新药物治疗法。
Gastroenterol Clin North Am. 2010 Sep;39(3):709-20. doi: 10.1016/j.gtc.2010.08.020.
5
Review article: from gastrin to gastro-oesophageal reflux disease--a century of acid suppression.综述文章:从胃泌素到胃食管反流病——一个世纪的抑酸治疗
Aliment Pharmacol Ther. 2006 Mar 15;23(6):683-90. doi: 10.1111/j.1365-2036.2006.02817.x.
6
Review article: acid-related disease--what are the unmet clinical needs?
Aliment Pharmacol Ther. 2006 Jun;23 Suppl 2:9-22. doi: 10.1111/j.1365-2036.2006.02944.x.
7
Gastroprotective drugs in Australia: utilization patterns between 1997 and 2006 in relation to NSAID prescribing.澳大利亚的胃保护药物:1997年至2006年期间与非甾体抗炎药处方相关的使用模式
Clin Ther. 2009 Apr;31(4):849-61. doi: 10.1016/j.clinthera.2009.04.012.
8
[The use of histamine H2 receptor blockaders in gastroenterology].
Tidsskr Nor Laegeforen. 1983 Apr 30;103(12):980-3.
9
Gastroenterology: 1987 and 2007.
JAAPA. 2007 Dec;20(12):49-50. doi: 10.1097/01720610-200712000-00013.
10
[The gastrointestinal risk of antiplatelet agents and nonsteroidal anti-inflammatory agents. A report of the American College of Cardiology Foundation (ACCF), the American College of Gastroenterology (ACG) and the American Heart Association (AHA)].[抗血小板药物和非甾体抗炎药的胃肠道风险。美国心脏病学基金会(ACCF)、美国胃肠病学会(ACG)和美国心脏协会(AHA)的报告]
Recenti Prog Med. 2009 May;100(5):277-8.

引用本文的文献

1
Laparoscopic and Open Surgical Treatment in Gastroduodenal Perforations: Our Experience.腹腔镜与开放手术治疗胃十二指肠穿孔:我们的经验
Surg Laparosc Endosc Percutan Tech. 2017 Apr;27(2):113-115. doi: 10.1097/SLE.0000000000000376.
2
Trends in diagnosis and surgical management of patients with perforated peptic ulcer.穿孔性消化性溃疡患者的诊断和手术治疗趋势。
J Gastrointest Surg. 2011 Aug;15(8):1329-35. doi: 10.1007/s11605-011-1482-1. Epub 2011 May 13.